Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04101968 · ClinicalTrials.gov registry record
The GBA Multimodal Study in Parkinson's Disease
A clinical trial of Parkinson Disease and Gaucher Disease, sponsored by Pacific Parkinson's Research Centre.
- Recruiting
- Registry status
- 25
- Enrollment target
- 3
- Study locations
NCT04101968 is a study of Parkinson Disease and Gaucher Disease that is actively recruiting participants, run by Pacific Parkinson's Research Centre. The registered enrollment target is 25 participants, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (100% lower). The trial reports 3 study locations across 3 states.
The verdict
NCT04101968, a study of Parkinson Disease and Gaucher Disease, is actively recruiting participants, sponsored by Pacific Parkinson's Research Centre.
- RECRUITING
- Registry status
- 25 participants
- Enrollment target
- 3
- Study locations
Study Summary
This study plans to analyze the molecular and clinical mechanisms of the relationship between the GBA mutations and Parkinson's disease. This will be assessed through the use of advanced neuroimaging techniques called PET (positron emission tomography) to study the accumulation of the tau protein and the dysfunction of acetylcholine and dopamine in the brain of people with a mutation in the GBA gene, with and without Parkinson's disease. The ingestigators will also use a technology-based assessment to study the typing patterns as possible biomarkers of early motor dysfunctions.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST PET scan
- DIAGNOSTIC_TEST neuroQWERTY
Study Locations (3)
Oregon
- Oregon Health & Science University - Portland
Washington
- University of Washington - Seattle
British Columbia
- Pacific Parkinson's Research Centre | University of British Columbia - Vancouver
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2019-05-01 |
| Est. Completion | 2025-12-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04101968
The ClinicalTrials.gov registry entry for NCT04101968 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (100% lower). The listed sponsor is Pacific Parkinson's Research Centre, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Parkinson Disease appearing as the primary indexed condition, and to 2 interventions - of which PET scan is the first listed.
NCT04101968 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Oregon, Washington, British Columbia.
Frequently Asked Questions
What is clinical trial NCT04101968 about?
NCT04101968 is a clinical study titled "The GBA Multimodal Study in Parkinson's Disease". This study plans to analyze the molecular and clinical mechanisms of the relationship between the GBA mutations and Parkinson's disease. This will be assessed through the use of advanced neuroimaging techniques called PET (positron emission tomography) to study the accumulation of the tau protein an...
What is the current status of trial NCT04101968?
This trial is currently recruiting. The enrollment target is 25 participants. The study started on 2019-05-01. Estimated completion is 2025-12-30.
What conditions does trial NCT04101968 study?
This clinical trial studies the following conditions: Parkinson Disease, Gaucher Disease, GBA Gene Mutation.
What interventions are being tested in trial NCT04101968?
The interventions under investigation include: PET scan (DIAGNOSTIC_TEST), neuroQWERTY (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04101968?
This trial is sponsored by Pacific Parkinson's Research Centre, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04101968 being conducted?
This trial has 3 study locations across Oregon, Washington, British Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Parkinson Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Evaluation of Correlation Between Oculometric Measures and Clinical Assessment in Parkinson's Disease
RECRUITING · NA
-
Colonoscopic Detection of Phosphorylated Alpha-synuclein for Parkinson's Diagnosis
RECRUITING
-
University of Delaware Parkinson's Disease Registry
RECRUITING
-
Neocortical Microarchitecture of Executive Function
RECRUITING · NA
-
Modification of Threat Interpretation Bias to Reduce Anxiety in Neurodegenerative Movement Disorders (Aim 3)
RECRUITING · NA
-
Intranasal Insulin and Glutathione as an Add-On Therapy in Parkinson's Disease
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.